6-K ·Filed Oct 5, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No material financial or operational impact, this is a routine administrative penalty. Monitor for any escalation or additional IRS scrutiny, but no near-term stock catalyst.
Latest settled: T+5d
RDY ▲ +4.06% at T+5d
NEUTRAL call +4.06% · α vs SPY +3.64% · entry $12.32 → $12.82
Latest observation: T+14 +12.63% FF3 residual α
T+1d
+1.38%
call +1.38% · α +0.83%
$12.49
settled 24d ago
T+5d
+4.06%
call +4.06% · α +3.64%
$12.82
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
Dr. Reddy's Laboratories filed a 6-K reporting a $32,350.20 IRS penalty on its U.S. subsidiary for misclassifying a fiscal year reference during tax payment. The company explicitly states no material impact on financials, operations, or other activities.
Key Facts
- Dr. Reddy's Laboratories, Inc. (DRL Inc.), a step-down wholly owned subsidiary, received an IRS penalty of $32,350.20.
- Penalty due to misclassification of fiscal year reference at the time of tax payment.
- Company states no material impact on financials, operations, or other activities.
- Penalty amount is immaterial relative to company size.
Financial Impact
$32,350.20 penalty, immaterial for a company of Dr. Reddy's scale
Risk Factors
- Potential for additional IRS scrutiny if pattern of filing errors exists
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000672 |
| Document: 0001575872-26-000672-index.html | 0001575872-26-000672 |
| Document: 0001575872-26-000672.txt | 0001575872-26-000672 |
67 reports for RDY
70% Hit rate @ T+5 Went positive at some point 7 of 11 best @ T+20▲ +23.28%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 today | 6-K | $14.15 | awaiting T+5 | awaiting T+5 | $14.15 (+0.04%) |
Oct 28, 2026 today | 6-K | $14.16 | awaiting T+5 | awaiting T+5 | $14.15 (−0.07%) |
Oct 26, 2026 3d ago | 6-K | $13.75 | awaiting T+5 | awaiting T+5 | $14.15 (+2.91%) |
Oct 26, 2026 3d ago | 6-K | $13.75 | awaiting T+5 | awaiting T+5 | $14.15 (+2.91%) |
Oct 23, 2026 6d ago | 6-K | No price | awaiting T+5 | awaiting T+5 | No price |
Oct 23, 2026 6d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.15 (+7.12%) |
Oct 23, 2026 6d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.15 (+7.12%) |
Oct 23, 2026 6d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.15 (−7.12%) |
Oct 21, 2026 8d ago | 6-K | $13.19 $13.75 | ▲ +4.25% | ▲ +4.69% | $14.15 (+7.28%) |
Oct 14, 2026 15d ago | 6-K | $12.75 $13.19 | ▲ +3.45% | ▲ +3.00% | $14.15 (+10.98%) |
Showing 10 of 67
US Market Status
Market Closed · Opens Mon (60h 59m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers